Chinese national free antiretroviral treatment cohort
This study aims to evaluate the effectiveness and outcomes of antiretroviral therapy (ART) by examining health and treatment responses in HIV-positive individuals. The study began in 2002 with a pilot programme in one county in Henan Province, involving approximately 7,000 participants. By the end of 2003, the programme had expanded to include nine provinces and became a nationwide cohort by 2004. In 2007, the study included over 42,000 participants, comprising both adult and paediatric cohorts. After treatment initiation, follow-up visits are scheduled at 0.5, 1, 2, and 3 months, and once every 3 months thereafter.
Study design
Cohort - open
Number of participants at first data collection
42,126 (adult participants)
799 (paediatric participants)
Recruitment is ongoing
Age at first data collection
≥ 15 years (adult participants)
< 15 years (paediatric participants)
Participant year of birth
Varied (adult participants)
Varied (paediatric participants)
Participant sex
All
Representative sample at baseline?
The HIV/AIDS treatment across all of China.
Sample features
Country
Year of first data collection
2002
Primary Institutions
Chinese Center for Disease Control and Prevention (中国疾病预防控制中心, CCDC) (Government, China)
National Center for AIDS/STD Control and Prevention (中国疾病预防控制中心性病艾滋病预防控制中心, NCAIDS) (Government, China)
Profile paper DOI
Funders
Ministry of Health (Government, China)
National Institutes of Health (NIH) (Government, United States of America)
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-completed questionnaire – paper or computer assisted
- None
- None
- None
Engagement
Keywords
